Robert Lorne Abel Insider Information
Executive Vice President and Chief Computational Scientist, joined Schrödinger in 2009, is responsible for advancing Schrödinger’s computational science platform. He also leads the computational chemistry team within Schrödinger’s drug discovery group. Robert obtained his PhD from Columbia University, where he was awarded NSF and DHS research fellowships. His thesis work with Professor Richard Friesner involved developing methods to quantify the role of solvent in protein-ligand binding. Robert has co-authored multiple patent applications, and continues to publish extensively on a wide variety of topics in computational chemistry.
What is Robert Lorne Abel's net worth?
The estimated net worth of Robert Lorne Abel is at least $487,749.88 as of June 21st, 2021. Dr. Abel owns 7,814 shares of Schrödinger stock worth more than $487,750 as of September 18th. This net worth evaluation does not reflect any other assets that Dr. Abel may own. Learn More.
How do I contact Robert Lorne Abel?
The corporate mailing address for Dr. Abel and other Schrödinger executives is 120 WEST 45TH STREET 17TH FLOOR, NEW YORK NY, 10036. Schrödinger can also be reached via phone at 212-295-5800 and via email at [email protected]
Has Robert Lorne Abel been buying or selling shares of Schrödinger?
During the last quarter, Robert Lorne Abel has sold $963,424.00 in shares of Schrödinger stock. Most recently, Robert Lorne Abel sold 15,602 shares of the business's stock in a transaction on Monday, September 13th. The shares were sold at an average price of $61.75, for a transaction totalling $963,423.50.
Who are Schrödinger's active insiders?
Are insiders buying or selling shares of Schrödinger?
During the last twelve months, insiders at the sold shares 103 times. They sold a total of 8,125,220 shares worth mmore than $531,786,383.42. The most recent insider tranaction occured on September, 15th when Karen Akinsanya Insider bought 1,394 shares worth more than $85,215.22. Insiders at Schrödinger own 5.0 % of the company.
Information on this page was last updated on 9/15/2021.
Robert Lorne Abel Insider Trading History at Schrödinger
|Transaction Date||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
Schrödinger Company Overview
SchrÃ¶dinger, Inc. provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates through two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. SchrÃ¶dinger, Inc. has strategic collaborations with Thermo Fisher Scientific to extend the use of cryo-EM in connection within silico compound screening to accelerate drug discovery; Bristol Myers Squibb Company to discover, develop, and commercialize therapeutics in multiple disease areas; and NVIDIA designed to harness DGX SuperPODs. The company was incorporated in 1990 and is headquartered in New York, New York.
50 Day Range
2 Week Range